Hematologist
CION Cancer Clinics
Low B cells after CAR-T and when antibody replacement helps | CION Cancer Clinics
B-cell aplasia means CAR-T has also cleared your healthy B cells, the cells that make antibodies. It is expected, and it often shows the treatment is still active. The cost is weaker defence against infection. If your antibody level falls low and infections keep coming, your team may give immunoglobulin replacement: antibodies from donated blood, through a drip or under the skin. This page explains how that decision is made. At CION Cancer Clinics, our haematology team assesses whether a transplant or CAR-T fits your situation and coordinates care with qualified centres.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is B-cell aplasia after CAR-T?
- What does low antibody protection look like day to day?
- How does the team decide whether you need replacement?
- Through a vein or under the skin: what is the difference?
- What do families get wrong about low antibodies after CAR-T?
- Who may not need it, and what can this page not tell you?
- Common questions about B-cell aplasia and IVIG
The short answer
What is B-cell aplasia after CAR-T?
B-cell aplasia means your body has almost no B cells left. B cells are the white cells that make antibodies, your long-term defence against germs. After CAR-T this is expected, and it is usually a sign the new cells are still working.
Why it happens
Most CAR-T cells for lymphoma and one type of leukaemia are built to find a marker called CD19. That marker sits on the cancer cells. It also sits on your healthy B cells. The CAR-T cells cannot tell the two apart, so they clear both. CAR-T for myeloma targets a different marker, but it also removes the cells that make antibodies, so the effect is similar.
How long it lasts
It varies a great deal. In some people B cells return within months. In others they stay absent for years, for as long as the CAR-T cells remain active. Your team cannot predict this for you in advance. They follow it with blood tests instead.
Why it matters to you
With few B cells, your antibody level slowly falls. On your report this is called low IgG, or low immunoglobulin, which simply means low antibodies. Infections may come more often, last longer or hit harder, especially chest and sinus infections.
Returning B cells can be welcome news or a signal to check the disease more closely. Only your team can read which it is.Living with low antibodies
What does low antibody protection look like day to day?
Most people notice nothing at all. The change shows up in how your body copes when a germ does get in.
Chest and sinus infections
These are the most common problem. A cough that lingers, green or yellow phlegm, or a blocked, painful face that does not settle within a few days is worth reporting.
Infections that keep returning
One infection is not unusual for anyone. The same infection coming back again and again, or needing course after course of antibiotics, is the pattern that makes teams consider replacement.
Vaccines that work less well
Without B cells, vaccines often fail to build protection. Old childhood vaccine protection may also fade.
Ask your team before
- Any vaccine, especially a live one
- Travel to areas with outbreaks
Everyday habits that help
Wash hands often. Avoid crowds and people with a cold where you can. Keep food and drinking water clean. Ask family members to stay up to date with their own vaccines, because that protects you too.
Not sure whether this applies to you?
Ask an oncologist
!
A fever cannot wait after CAR-T
If you get a fever, shivering, breathlessness or sudden confusion at any point after CAR-T, go to the nearest emergency department the same day, or call 108. Tell them you have had CAR-T and have low antibodies. Carry your discharge summary. Do not wait to see whether it settles, and do not start leftover antibiotics at home.
How it is followed
How does the team decide whether you need replacement?
-
A B-cell count on follow-up blood tests
Your team checks whether B cells are present. The report may call this a CD19 count or B-cell count. An absent result is expected after CAR-T and is not in itself a problem.
-
Antibody levels over time
An IgG level is checked at intervals. One reading means little on its own. Laboratories use different reference ranges, so your team looks at the trend and at how you are keeping.
-
Your infection history
How often you have been unwell, how badly and what treatment it needed. Keep a simple diary with dates and any hospital visits. It is often the most useful thing you bring.
-
A decision, then a review
If levels are low and infections are frequent or serious, replacement is usually offered. Some teams also give it when levels are very low even without infections. It is reviewed regularly, and stopped when your own B cells and antibodies return.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Two ways to give it
Through a vein or under the skin: what is the difference?
Into a vein (IVIG)
Under the skin (SCIG)
Given as a drip in a day-care unit, over a few hours
Given through a small needle under the skin of the tummy or thigh
Usually about once a month
Smaller amounts, more often, often at home after training
Headache and tiredness afterwards are fairly common
Local swelling or soreness where the needle went in is common
Suits people who prefer a nurse to handle it
Suits people who find travel to hospital hard
Commonly believed
What do families get wrong about low antibodies after CAR-T?
"No B cells means the CAR-T has damaged him."
It is the opposite in most cases. The CAR-T cells are doing what they were built to do, and clearing healthy B cells is part of that. The goal is to protect you from infection while it lasts, not to reverse it.
"Once replacement starts, it is for life."
Not usually. It is given while your own antibody production is missing. When B cells come back and levels recover, many people can stop, with the team deciding when and checking levels afterwards.
"Immunoglobulin is a strong drug with serious risks."
It is made of antibodies collected from many healthy blood donors and carefully purified. Reactions do happen, mostly headache, chills or tiredness during or after a dose, and the nurse slows or pauses the drip if they do. Serious reactions are uncommon.
"With replacement, she is fully protected now."
Replacement lowers the risk. It does not remove it. Hand washing, clean food and water, and early reporting of fever still matter just as much as before.
Being straight with you
Who may not need it, and what can this page not tell you?
Not everyone with B-cell aplasia needs replacement. If your antibody level holds up reasonably well and you rarely get infections, most teams watch and wait. People with a history of reactions to blood products, or with certain kidney or clotting problems, need extra care before any dose, so tell the team about these early.
What this page cannot tell you
It cannot tell you whether your own IgG result is low enough to act on, how often you would need a dose, or how long B cells will stay away. Those depend on the CAR-T product you had, your disease and your infection history. Never start, skip or stop a dose on your own.
Getting it closer to home
Many families from Telangana and Andhra Pradesh districts had CAR-T at a centre far away. Regular drips can often be given nearer home once the treating centre agrees a written plan. Ask for that plan in writing, including which result or symptom should prompt a call back. Immunoglobulin is costly, so check early what your insurer, Aarogyasri, CGHS, ECHS, EHS or PM-JAY cover allows, as scheme rules change. CION's haematology team can review your reports and help coordinate follow-up with your treating centre.
Questions we are asked
Common questions about B-cell aplasia and IVIG
Is B-cell aplasia a bad sign after CAR-T?
Usually not. It tends to show that the CAR-T cells are still active in your body. The concern is not the missing B cells themselves but the extra infection risk that comes with them. Your team manages that risk with monitoring, infection advice and, where needed, antibody replacement.
Does the return of B cells mean the cancer is back?
Not necessarily. B cells can come back simply because the CAR-T cells have faded, while the disease stays away. In some people the team will check the disease more closely at that point. Do not read meaning into the result alone. Ask your haematologist what it means for you.
Where does immunoglobulin come from?
It is made from the plasma, the liquid part of blood, given by a large number of healthy donors. The antibodies are separated, purified and treated to remove germs. Because it is a blood product, you will be asked for consent, and the batch number is recorded each time you receive it.
What does an IVIG day look like?
You come to the day-care unit, have your temperature and blood pressure checked, and the drip is started slowly. The speed is raised if you are comfortable. You can eat, drink, read and have a family member with you. Most people go home the same day. Drink plenty of water before and after.
Can I get vaccines while my B cells are low?
Only with your team's advice. Live vaccines are generally avoided for a long time after CAR-T. Other vaccines may be offered at set times, though they often work less well while B cells are absent. Ask for a written vaccine plan, and ask that close family keep their own vaccines current.
Can my children and grandchildren visit?
Yes, in most cases. Ask visitors who have a cold, fever, loose motions or a rash to wait until they are well. Hand washing on arrival helps. Check with your team about children who have just had a live vaccine, as some advice applies for a short period afterwards.
Can I travel or go back to work?
Many people do, once the team is happy with your recovery. Plan around your replacement schedule and follow-up tests. Carry your discharge summary and a note about your low antibodies. Know where the nearest emergency department is wherever you go, in case a fever starts.
Is immunoglobulin covered by insurance or schemes?
It depends on your policy and scheme, and cover for ongoing doses varies. Ask the treating centre for a letter explaining why replacement is needed. Check with your insurer or Aarogyasri, CGHS, ECHS, EHS or PM-JAY desk, as rules change. Our helpline can help you work out what to ask.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- American Cancer Society — CAR T-cell Therapy and Its Side Effects
- National Cancer Institute — CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers
- Cancer Research UK — CAR T-cell therapy
- Cancer.Net — What is CAR T-cell therapy?
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Long-Term Monitoring After CAR-TEvery check in the years after CAR-T, not only antibodiesRelapse After CAR-TWhat happens if follow-up finds the disease has returnedBlood counts during chemotherapyHow to read the counts on your blood reportCAR-T: The GapsEvery stage of CAR-T, from referral to follow-up
Talk to us
Had CAR-T and worried about infections?
Tell us what has been done so far. Our haematology team can review your reports and help you plan follow-up with your treating centre. One helpline serves every CION centre.